Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Kevin Bi

Showing results (31-40 of 39) with videos related to

Pageof 4
Sort By:
You have reached the last page of results.This site can display upto 39 results.
Nature|December 19, 2018
Loss of ADAR1 in tumours overcomes resistance to immune checkpoint blockadeJeffrey J Ishizuka, Robert T Manguso, Collins K Cheruiyot, et al.
Proceedings of the National Academy of Sciences of the United States of America|October 4, 2024
Toward a CRISPR-based mouse model of <i>Vhl</i>-deficient clear cell kidney cancer: Initial experience and lessons learnedLaura A Stransky, Wenhua Gao, Laura S Schmidt, et al.
Science Advances|September 27, 2023
Intertumoral lineage diversity and immunosuppressive transcriptional programs in well-differentiated gastroenteropancreatic neuroendocrine tumorsSamantha E Hoffman, Todd W Dowrey, Carlos Villacorta Martin, et al.
JCI Insight|April 30, 2024
Innate immune activation restricts priming and protective efficacy of the radiation-attenuated PfSPZ malaria vaccineLeetah Senkpeil, Jyoti Bhardwaj, Morgan R Little, et al.
Nature Medicine|March 5, 2021
Transcriptional mediators of treatment resistance in lethal prostate cancerMeng Xiao He, Michael S Cuoco, Jett Crowdis, et al.
Nature Medicine|May 4, 2021
Evolution of delayed resistance to immunotherapy in a melanoma responderDavid Liu, Jia-Ren Lin, Emily J Robitschek, et al.
Nature Communications|May 15, 2026
Carboplatin with or without nivolumab in metastatic triple-negative breast cancer: a randomized phase II trialAna C Garrido-Castro, Noah Graham, Katelyn X Li, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 2, 2025
Tumor-Intrinsic and Microenvironmental Determinants of Impaired Antitumor Immunity in Chromophobe Renal Cell CarcinomaChris Labaki, Eddy Saad, Katrine N Madsen, et al.
Nature Communications|February 6, 2021
Integrative molecular characterization of sarcomatoid and rhabdoid renal cell carcinomaZiad Bakouny, David A Braun, Sachet A Shukla, et al.
Pageof 4

Showing results (31-40 of 39) with videos related to

Sort By:
Pageof 4
You have reached the last page of results.This site can display upto 39 results.
Nature|December 19, 2018
Loss of ADAR1 in tumours overcomes resistance to immune checkpoint blockadeJeffrey J Ishizuka, Robert T Manguso, Collins K Cheruiyot, et al.
Proceedings of the National Academy of Sciences of the United States of America|October 4, 2024
Toward a CRISPR-based mouse model of <i>Vhl</i>-deficient clear cell kidney cancer: Initial experience and lessons learnedLaura A Stransky, Wenhua Gao, Laura S Schmidt, et al.
Science Advances|September 27, 2023
Intertumoral lineage diversity and immunosuppressive transcriptional programs in well-differentiated gastroenteropancreatic neuroendocrine tumorsSamantha E Hoffman, Todd W Dowrey, Carlos Villacorta Martin, et al.
JCI Insight|April 30, 2024
Innate immune activation restricts priming and protective efficacy of the radiation-attenuated PfSPZ malaria vaccineLeetah Senkpeil, Jyoti Bhardwaj, Morgan R Little, et al.
Nature Medicine|March 5, 2021
Transcriptional mediators of treatment resistance in lethal prostate cancerMeng Xiao He, Michael S Cuoco, Jett Crowdis, et al.
Nature Medicine|May 4, 2021
Evolution of delayed resistance to immunotherapy in a melanoma responderDavid Liu, Jia-Ren Lin, Emily J Robitschek, et al.
Nature Communications|May 15, 2026
Carboplatin with or without nivolumab in metastatic triple-negative breast cancer: a randomized phase II trialAna C Garrido-Castro, Noah Graham, Katelyn X Li, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 2, 2025
Tumor-Intrinsic and Microenvironmental Determinants of Impaired Antitumor Immunity in Chromophobe Renal Cell CarcinomaChris Labaki, Eddy Saad, Katrine N Madsen, et al.
Nature Communications|February 6, 2021
Integrative molecular characterization of sarcomatoid and rhabdoid renal cell carcinomaZiad Bakouny, David A Braun, Sachet A Shukla, et al.
Pageof 4